AAV-Associated Hepatocellular Carcinoma

Time: 4:45 pm
day: Day One


  • High dose systemic AAV administration in newborn mice is associated with an increased incidence of HCC
  • AAV-associated HCC is a protracted phenotype
  • AAV administration combined with other treatments that may have some oncogenic potential greatly increases the incidence of HCC